Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

5.510 -0.101 (-1.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jaguar Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024
Via ACCESSWIRE
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via ACCESSWIRE
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
Via AB Newswire
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Via ACCESSWIRE
Jaguar Health, Inc. Announces Reverse Stock Split
Via ACCESSWIRE
Jaguar Health Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
Via ACCESSWIRE
Peering Into Jaguar Health's Recent Short Interest
Via Benzinga
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
Via ACCESSWIRE
What's Going On With Jaguar Health Stock?
Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order to support the company's compliance with Nasdaq listing standards. 
Via Benzinga
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
Via ACCESSWIRE
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
Via Benzinga
Topics Stocks
Exposures US Equities
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Jaguar Health Stock Is Tanking
Jaguar Health shares are falling Monday after the company announced a 1-for-60 reverse stock split. The company will effect a reverse stock split at an exchange ratio of 1-for-60, on Thursday, in order... 
Via Benzinga
Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
Via Benzinga
Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?
Red Lobster bankruptcy is a hot topic among traders on Monday after the popular seafood chain submitted a voluntary filing this morning. 
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
Via Benzinga
Why Is Jaguar Health (JAGX) Stock Down 40% Today?
Jaguar Health stock is down on Monday after the company announced plans for a reverse split of JAGX later this week. 
Via InvestorPlace
Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
JAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q1 2024
JAGX stock results show that Jaguar Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
Via ACCESSWIRE
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now
Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out this morning as we dive into all of the biggest news moving shares on Friday! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.